Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | high affinity choline transporter 1 | 0.0361 | 0.6774 | 0.9934 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0449 | 1 | 1 |
Echinococcus multilocularis | 0.0362 | 0.6819 | 1 | |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0273 | 0.355 | 0.355 |
Brugia malayi | celfurPC protein | 0.0362 | 0.6819 | 0.4795 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0273 | 0.355 | 0.5 |
Echinococcus granulosus | furin | 0.0449 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0449 | 1 | 1 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0195 | 0.0709 | 0.0709 |
Schistosoma mansoni | high-affinity choline transporter | 0.0361 | 0.6774 | 0.6774 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0282 | 0.389 | 0.5704 |
Brugia malayi | GH02984p | 0.0361 | 0.6774 | 0.4721 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0273 | 0.355 | 0.5206 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0282 | 0.389 | 0.389 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0273 | 0.355 | 0.5 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0449 | 1 | 1 |
Echinococcus granulosus | high affinity choline transporter 1 | 0.0361 | 0.6774 | 0.6774 |
Loa Loa (eye worm) | hypothetical protein | 0.0361 | 0.6774 | 0.6773 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.5 uM | Antiviral activity against HIV-1 infected human MT-4 cells. | ChEMBL. | 11384233 |
IC50 (functional) | > 200 uM | Cell culture cytotoxicity against MT-4 cells. | ChEMBL. | 11384233 |
IC50 (functional) | > 200 uM | Cell culture cytotoxicity against MT-4 cells. | ChEMBL. | 11384233 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.